Stroke Clinical Trials in Los Angeles, California

10 studies are recruiting for stroke in Los Angeles, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

   This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limi…

   Stage

   Phase 2

   Ages

   18 to 90

   Site

   Kaiser Permanente Los Angeles Medical Center, Los Angeles, California

   Locations

   86 in total

   Run by

   DiaMedica Therapeutics Inc

   See if you can join NCT05065216 on ClinicalTrials.gov

2. Telerehabilitation In The Home After Stroke

   The purpose of this research study is to evaluate whether telerehabilitation targeting arm movement, when added to usual care, improves arm function and reduces global disability after stroke, compared to usual care alone. Patients with arm weakness due to stroke that happened in the past 90-150 da…

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Keck Medical Center of USC, Los Angeles, California

   Locations

   27 in total

   Run by

   University of California, Los Angeles

   See if you can join NCT06682429 on ClinicalTrials.gov

3. Treatment With Endovascular Intervention for STroke Patients With Existing Disability

   TESTED will compare the risks and benefits of endovascular thrombectomy (EVT) to medical management (no EVT) in ischemic stroke patients who have a blockage in one of the large blood vessels in the brain and have a moderate-to-severe disability prior to their stroke.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Kaiser Permanente Los Angeles Medical Center, Los Angeles, California

   Locations

   35 in total

   Run by

   University of Cincinnati

   See if you can join NCT05911568 on ClinicalTrials.gov

4. Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

   VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore these biomarkers in acute intracerebral hemorrhage. VERIFY will create the first multicenter, large-scale, prospective dataset of clinical, tra…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Keck Medical Center of USC, Los Angeles, California

   Locations

   45 in total

   Run by

   Yale University

   See if you can join NCT05338697 on ClinicalTrials.gov

5. Cognition and Imaging With Tigertriever

   The objective of the COGNITIVE Study is to evaluate whether successful reperfusion with Tigertriever is associated with cognitive benefit.

   Stage

   Not phased

   Ages

   18 to 75

   Site

   University of California, Los Angeles, California

   Locations

   3 in total

   Run by

   Rapid Medical

   See if you can join NCT05531461 on ClinicalTrials.gov

6. Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke Patients

   The purpose of this research is to evaluate a new investigational device for the diagnosis of stroke, the EMVision emu™ Brain Scanner. Stroke is the result of a blood clot stopping the normal flow of blood in the brain (ischaemic stroke) or a breakage in a blood vessel causing bleeding in the brain…

   Stage

   Not phased

   Ages

   22 and older

   Site

   UCLA, Los Angeles, California

   Locations

   8 in total

   Run by

   EMVision Medical Devices Ltd

   See if you can join NCT06999122 on ClinicalTrials.gov

7. Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

   The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated c…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   University of Southern California, Los Angeles, California

   Locations

   106 in total

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT04045665 on ClinicalTrials.gov

8. Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis

   An observational study to determine if individuals with increased platelet FcyRIIa will have a higher risk of ischemic events.

   Stage

   Not phased

   Ages

   30 and older

   Site

   Ronald Reagan UCLA Medical Center, Los Angeles, California

   Run by

   University of California, Los Angeles

   See if you can join NCT05518305 on ClinicalTrials.gov

9. Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress

   Multinational, investigator-initiated study of oral anticoagulation versus no anticoagulation for the prevention of stroke and other adverse cardiovascular events in patients with transient atrial fibrillation occurring transiently with stress and additional stroke risk factors.

   Stage

   Phase 4

   Ages

   55 and older

   Site

   Cedars-Sinai Medical Center, Los Angeles, California

   Locations

   105 in total

   Run by

   Population Health Research Institute

   See if you can join NCT03968393 on ClinicalTrials.gov

10. Cognition and Motor Learning Post-stroke

    This project seeks to determine how post-stroke cognitive impairment moderates motor learning during walking in older adults with chronic stroke and identify brain structural markers that mediate this relationship. The chosen experimental design integrates biomechanical analyses, neuropsychological…

    Stage

    EARLY_Phase 1

    Ages

    45 to 85

    Site

    Center for Health Professions, Los Angeles, California

    Run by

    University of Southern California

    See if you can join NCT04829071 on ClinicalTrials.gov